Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder

ClinicalTrials.gov ID: NCT02318602

Public ClinicalTrials.gov record NCT02318602. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 6:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Open-label, Flexible Dose Study to Assess the Long-term Safety of Pharmaceutical Cannabidiol Oral Solution as an Adjunctive Treatment for Pediatric Subjects With a Treatment-resistant Seizure Disorder Who Complete INS011-14-029 or Part A of INS011-15-054

Study identification

NCT ID
NCT02318602
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
INSYS Therapeutics Inc
Industry
Enrollment
52 participants

Conditions and interventions

Conditions

Interventions

  • Cannabidiol Oral Solution Drug

Drug

Eligibility (public fields only)

Age range
1 Year to 18 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 7, 2016
Primary completion
Jun 21, 2017
Completion
Jun 21, 2017
Last update posted
Jul 25, 2018

2016 – 2017

United States locations

U.S. sites
11
U.S. states
10
U.S. cities
11
Facility City State ZIP Site status
University of California San Francisco Medical Center San Francisco California 94143
Miami Children's Hospital Miami Florida 33155
Child Neurology Center - NW F Pensacola Florida 32504
University of Chicago Medical Center Chicago Illinois 60637
Clinical Research Center of Nevada LLC Las Vegas Nevada 89104
Oregon Health Services University Portland Oregon 97239
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
Le Bonheur Children's Hospital Memphis Tennessee 38103
Texas Scottish Rite Hospital for Children Dallas Texas 79219
Granger Medical Clinic Riverton Utah 84096
Mary Bridge Children's Hospital Tacoma Washington 98403

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02318602, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 25, 2018 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02318602 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →